SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001315863-24-000263
Filing Date
2024-02-14
Accepted
2024-02-14 15:45:13
Documents
1
Group Members
ANTARA CAPITAL GP LLCHIMANSHU GULATI

Document Format Files

Seq Description Document Type Size
1 form_sc13ga_revance.htm SC 13G/A 71745
  Complete submission text file 0001315863-24-000263.txt   73414
Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Subject) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88023 | Film No.: 24637078
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 55 HUDSON YARDS 47TH FLOOR NEW YORK NY 10001
Business Address 55 HUDSON YARDS 47TH FLOOR NEW YORK NY 10001 646-762-8580
Antara Capital LP (Filed by) CIK: 0001750183 (see all company filings)

IRS No.: 824823093 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A